Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Symptomatic Venous Thromboembolic Events and Major Bleeding Events After Dabigatran Etexilate in Patients Subject to Subject to Elective Total Hip or Knee Replacement Surgery.

NCT00967447 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00967447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00967447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Symptomatic Venous Thromboembolic Events and Major Bleeding Events After Dabigatran Etexilate in Patients Subject to Subject to Elective Total Hip or Knee Replacement Surgery.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Terminated
Start date
February 1, 2009
Completion date
Not reported
Enrollment
2 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, hip, thromboembolism